Abnormal myocardial function is related to myocardial steatosis and diffuse myocardial fibrosis in HIV-infected adults

Diana K. Thiara, Chia Ying Liu, Fabio Raman, Sabrina Mangat, Julia B. Purdy, Horacio A. Duarte, Nancyanne Schmidt, Jamie Hur, Christopher T. Sibley, David A. Bluemke, Colleen Hadigan

Research output: Contribution to journalArticlepeer-review

81 Scopus citations


Background. Impaired cardiac function persists in the era of effective human immunodeficiency virus (HIV) therapy, although the etiology is unclear. We used magnetic resonance imaging (MRI) to measure intramyocardial lipid levels and fibrosis as possible contributors to HIV-associated myocardial dysfunction. Methods. A cross-sectional study of 95 HIV-infected and 30 matched-healthy adults, without known cardiovascular disease (CVD) was completed. Intramyocardial lipid levels, myocardial fibrosis, and cardiac function (measured on the basis of strain) were quantified by MRI. Results. Systolic function was significantly decreased in HIV-infected subjects as compared to controls (mean radial strain [±SD], 21.7 ± 8.6% vs 30.5 ± 14.2%; P = .004). Intramyocardial lipid level and fibrosis index were both increased in HIV-infected subjects as compared to controls (P ≤ .04 for both) and correlated with the degree of myocardial dysfunction measured by strain parameters. Intramyocardial lipid levels correlated positively with antiretroviral therapy duration and visceral adiposity. Further, impaired myocardial function was strongly correlated with increased monocyte chemoattractant protein 1 levels (r = 0.396, P = .0002) and lipopolysaccharide binding protein levels (r = 0.25, P = .02). Conclusions. HIV-infected adults have reduced myocardial function as compared to controls in the absence of known CVD. Decreased cardiac function was associated with abnormal myocardial tissue composition characterized by increased lipid levels and diffuse myocardial fibrosis. Metabolic alterations related to antiretroviral therapy and chronic inflammation may be important targets for optimizing long-term cardiovascular health in HIV-infected individuals.

Original languageEnglish (US)
Pages (from-to)1544-1551
Number of pages8
JournalJournal of Infectious Diseases
Issue number10
StatePublished - Nov 15 2015
Externally publishedYes

Bibliographical note

Funding Information:
Financial support. This work was supported by the National Institutes of Health (NIH; NIH Bench to Bedside Award and intramural NIH clinical researching funding from the National Institute of Allergy and Infectious Disease and the NIH Clinical Center Departments of Imaging Sciences and Critical Care Medicine). Potential conflicts of interest. All authors: No reported conflicts.


  • Antiretroviral therapy
  • HIV
  • Intramyocardial lipid
  • Magnetic resonance spectroscopy
  • Myocardial strain


Dive into the research topics of 'Abnormal myocardial function is related to myocardial steatosis and diffuse myocardial fibrosis in HIV-infected adults'. Together they form a unique fingerprint.

Cite this